Treatment

SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic use (Phase IV)
Impact of GLP1-RAs on inflammation and endothelial biomarkerS in Type 2 diABetes meLlitus patiEnts: STABLE-GLP1 trial.
This study looks at how a diabetes medicine, semaglutide, affects inflammation and blood vessel health in people with Type 2 diabetes. We want to see if adding semaglutide to regular treatment helps reduce harmful effects in the body compared to standard treatment alone.
For: Type 2 diabetes mellitus
Italy